These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Do all patients with carcinoma of the esophagus benefit from treatment at teaching facilities? Cheung MC, Koniaris LG, Yang R, Zhuge Y, Mackinnon JA, Byrne MM, Franceschi D. J Surg Oncol; 2010 Jul 01; 102(1):18-26. PubMed ID: 20213687 [Abstract] [Full Text] [Related]
23. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Lee PC, Port JL, Paul S, Stiles BM, Altorki NK. Ann Thorac Surg; 2009 Jul 01; 88(1):186-92; discussion 192-3. PubMed ID: 19559222 [Abstract] [Full Text] [Related]
24. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Rice TW, Khuntia D, Rybicki LA, Adelstein DJ, Vogelbaum MA, Mason DP, Murthy SC, Blackstone EH. Ann Thorac Surg; 2006 Dec 01; 82(6):2042-9, 2049.e1-2. PubMed ID: 17126108 [Abstract] [Full Text] [Related]
25. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J, Prieto J. Liver Transpl; 2005 Jan 01; 11(1):89-97. PubMed ID: 15690541 [Abstract] [Full Text] [Related]
26. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia. Liu JF, Jamieson GG, Wu TC, Zhu GJ, Drew PA. Ann Surg Oncol; 2009 May 01; 16(5):1397-402. PubMed ID: 19241108 [Abstract] [Full Text] [Related]
27. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP. Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [Abstract] [Full Text] [Related]
28. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Internullo E, Moons J, Nafteux P, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Lerut T. Eur J Cardiothorac Surg; 2008 Jun 01; 33(6):1096-104. PubMed ID: 18407509 [Abstract] [Full Text] [Related]
30. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Toso C, Meeberg GA, Bigam DL, Oberholzer J, Shapiro AM, Gutfreund K, Ma MM, Mason AL, Wong WW, Bain VG, Kneteman NM. Transplantation; 2007 May 15; 83(9):1162-8. PubMed ID: 17496530 [Abstract] [Full Text] [Related]
31. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Scatton O, Zalinski S, Terris B, Lefevre JH, Casali A, Massault PP, Conti F, Calmus Y, Soubrane O. Liver Transpl; 2008 Jun 15; 14(6):779-88. PubMed ID: 18508370 [Abstract] [Full Text] [Related]